Engineering cancer dormancy as a collective emergent phenomenon: from matrix-enabled dormancy to collective dormancy-on-a-chip
DORMATRIX aims to engineer breast cancer dormancy as a collective emergent phenomenon using biomaterials-based devices to delay or prevent metastatic growth through advanced modeling and imaging.
Projectdetails
Introduction
Cancer dormancy and the trigger to transition to active metastatic growth is a big open question. Current in vivo models focus on niche-specific cell and molecular mechanisms, ignoring biophysical aspects. Dormancy evolves with complex spatio-temporal dynamics; yet, there is a knowledge gap in the understanding of the heterogeneity of the units, and the dynamics of their interaction and evolution.
Emergence of Macro-Level Organization
Emergence occurs when a critical mass of units synergistically communicates, giving rise to a new macro-level organization, with properties greater than the sum of the units. Engineering emergent phenomena in biological systems is a big research challenge as they originate from multiscale communication.
DORMATRIX Proposal
In DORMATRIX, I propose a radically new view. I hypothesize that the balance between cancer dormancy and “awakening” is a collective emergent phenomenon, whereby a critical mass of micro-units communicates with each other and the environment in order to transition to metastatic growth.
Objectives of DORMATRIX
The main objective of DORMATRIX is to engineer breast cancer (BC) dormancy as a collective emergent phenomenon using biomaterials-based dormancy-on-a-chip devices.
Previous Findings
My previous data shows that we can:
- Apply biophysical cues to control BC proliferation.
- Visualize in vivo early BC bone metastasis.
Multidisciplinary Approach
I will now address this outstanding challenge with a multidisciplinary approach:
- Apply biophysical principles with novel biomaterials to model in vitro cancer micro-units.
- Develop advanced 3D imaging to visualize collective cancer dormancy and bone microdamage.
- Develop in silico models based on evolutionary game theory to predict the dynamics.
- Prove my hypothesis with dormancy-on-a-chip devices.
Future Implications
Understanding the critical mass and multiscale communication required for emergent phenomena will enable the development of novel therapies to delay or prevent metastasis. The resulting technology for engineering emergent phenomena will spark research on other biological systems.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.349.943 |
Totale projectbegroting | € 2.349.943 |
Tijdlijn
Startdatum | 1-10-2024 |
Einddatum | 30-9-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOGIPUZKOApenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Mechanobiology of cancer progressionThis project aims to develop an innovative in vivo platform to study tumor fibrosis and improve targeted cancer therapies by mimicking the fibrotic microenvironment of breast cancer. | ERC Advanced... | € 2.498.690 | 2022 | Details |
Propagation of cellular memory through dormancyDOR-CODE aims to uncover the genomic mechanisms of embryonic dormancy to enhance understanding of cellular identity propagation and improve embryo preservation techniques. | ERC Starting... | € 1.488.750 | 2024 | Details |
COmputational DEsign for 4D BIOfabrication: harnessing programmable materials for dynamic pre-clinical cancer modelsCoDe4Bio aims to revolutionize cancer research by developing programmable 4D biofabricated models to better understand dynamic physical cues and improve pre-clinical drug screening. | ERC Starting... | € 1.495.100 | 2023 | Details |
Personalised Mechanobiological Models to Predict Tumour Growth and Anti-Cancer Drug PenetrationThis project aims to develop a personalized cancer treatment framework by modeling stress-dependent tumor growth and drug penetration to enhance patient-specific therapy outcomes. | ERC Starting... | € 1.499.693 | 2024 | Details |
Regaining control of cancer at biological bordersBorderControl aims to identify molecular signals and mechanisms that enable cancer cells to breach physiological barriers, with the goal of uncovering novel biomarkers and therapeutic targets for metastasis. | ERC Advanced... | € 2.500.000 | 2024 | Details |
Mechanobiology of cancer progression
This project aims to develop an innovative in vivo platform to study tumor fibrosis and improve targeted cancer therapies by mimicking the fibrotic microenvironment of breast cancer.
Propagation of cellular memory through dormancy
DOR-CODE aims to uncover the genomic mechanisms of embryonic dormancy to enhance understanding of cellular identity propagation and improve embryo preservation techniques.
COmputational DEsign for 4D BIOfabrication: harnessing programmable materials for dynamic pre-clinical cancer models
CoDe4Bio aims to revolutionize cancer research by developing programmable 4D biofabricated models to better understand dynamic physical cues and improve pre-clinical drug screening.
Personalised Mechanobiological Models to Predict Tumour Growth and Anti-Cancer Drug Penetration
This project aims to develop a personalized cancer treatment framework by modeling stress-dependent tumor growth and drug penetration to enhance patient-specific therapy outcomes.
Regaining control of cancer at biological borders
BorderControl aims to identify molecular signals and mechanisms that enable cancer cells to breach physiological barriers, with the goal of uncovering novel biomarkers and therapeutic targets for metastasis.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
3D spheroids derived from single cells for discovering stochastic patterns behind metastasis3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis. | EIC Pathfinder | € 2.591.050 | 2023 | Details |
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancyThe PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance. | EIC Pathfinder | € 2.982.792 | 2022 | Details |
3D spheroids derived from single cells for discovering stochastic patterns behind metastasis
3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.